DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Buy, Sell or Hold: JM Financial initiates coverage on IndoStar Capital Finance; Emkay maintains Accumulate on D-Mart

Economic Times 6d ago·13 Jul 2026, 4:10 am

Brokerages remained selective in their latest stock calls, backing Avenue Supermarts, LTM and IndoStar Capital Finance despite macro uncertainties. Elara sees margin-led growth for DMart, Emkay remains positive on LTM's deal pipeline and GenAI opportunities, while JM Financial initiated coverage on IndoStar with a 'Buy' rating, citing its retail-focused transformation and strong earnings growth potential.

Stocks in this story

Indostar Capital FIN₹269.55▲ 0.00%DMARTLTM